Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
 Disease Category: Asthma
Location: United States, NC

Trial Information

16 week Study for Patients with Asthma being treated with Advair, Flovent or Equivalent

This purpose of this study is to evaluate the effectiveness of the drug Reslizumab in Treatment of Patients with Moderate to Severe Asthma

Patient Inclusion Criteria:

  • Age 18-65
  • Currently taking Fluticasone (Advair, Flovent or Equivalent) >440mg daily

Patient Exclusion Criteria:

  • Smokers within last 6 months
  • Use of Xolair within last 6 months
  • Previous use of Reslizumab or mepolizumab

Mary Preisel, Marketing/Clinical Research Coordinator
American Health Research
1918 Randolph Rd, Suite 440
Charlotte, NC 28207
Phone: 704-325-6700
Fax: 704-926-8048
Email: Mpreisel@ahres.com

View Map

Research Center Information: American Health Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.